Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
作者： Bernard Leroy , Mandy L. Ballinger , Fanny Baran-Marszak , Gareth L. Bond , Antony Braithwaite
DOI: 10.1158/0008-5472.CAN-16-2179
关键词:
摘要: … Furthermore, germline rearrange-ments in intron 1 of TP53 are associated with LFS and are … when assessing TP53 status in clinical samples. Finally, we discuss how TP53 alterations …
aacrjournals.org
utsystem.edu参考文章(87)
T Soussi, K G Wiman, TP53: an oncogene in disguise Cell Death & Differentiation. ,vol. 22, pp. 1239- 1249 ,(2015) , 10.1038/CDD.2015.53
Juliana Giacomazzi, Simone G. Selistre, Cristina Rossi, Barbara Alemar, Patricia Santos-Silva, Fernando S. Pereira, Cristina B. Netto, Silvia L. Cossio, Daniela E. Roth, Algemir L. Brunetto, Marcelo Zagonel-Oliveira, Ghyslaine Martel-Planche, Jose R. Goldim, Pierre Hainaut, Suzi A. Camey, Patricia Ashton-Prolla, Li-Fraumeni and Li-Fraumeni—like syndrome among children diagnosed with pediatric cancer in Southern Brazil Cancer. ,vol. 119, pp. 4341- 4349 ,(2013) , 10.1002/CNCR.28346
Simone Hettmer, Natasha M. Archer, Gino R. Somers, Ana Novokmet, Amy J. Wagers, Lisa Diller, Carlos Rodriguez-Galindo, Lisa A. Teot, David Malkin, Anaplastic Rhabdomyosarcoma in TP53 Germline Mutation Carriers Cancer. ,vol. 120, pp. 1068- 1075 ,(2014) , 10.1002/CNCR.28507
Jean-Christophe Marine, MDM2 and MDMX in cancer and development. Current Topics in Developmental Biology. ,vol. 94, pp. 45- 75 ,(2011) , 10.1016/B978-0-12-380916-2.00003-6
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E. Garber, Christina Herold, Leif Ellisen, Jill Krejdovsky, Kim DeLeonardis, Kristin Sedgwick, Kathleen Soltis, Benjamin Roa, Richard J. Wenstrup, Anne-Renee Hartman, Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next‐generation sequencing with a 25‐gene panel Cancer. ,vol. 121, pp. 25- 33 ,(2015) , 10.1002/CNCR.29010
E. M. Alexandrova, A. R. Yallowitz, D. Li, S. Xu, R. Schulz, D. A. Proia, G. Lozano, M. Dobbelstein, U. M. Moll, Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment Nature. ,vol. 523, pp. 352- 356 ,(2015) , 10.1038/NATURE14430
Jing Qi, Sandeep Singh, Wei-Kai Hua, Qi Cai, Shi-Wei Chao, Ling Li, Hongjun Liu, Yinwei Ho, Tinisha McDonald, Allen Lin, Guido Marcucci, Ravi Bhatia, Wei-Jan Huang, Chung-I Chang, Ya-Huei Kuo, HDAC8 Inhibition Specifically Targets Inv(16) Acute Myeloid Leukemic Stem Cells by Restoring p53 Acetylation Cell Stem Cell. ,vol. 17, pp. 597- 610 ,(2015) , 10.1016/J.STEM.2015.08.004
Evgeny Izumchenko, Xiaofei Chang, Mariana Brait, Elana Fertig, Luciane T Kagohara, Atul Bedi, Luigi Marchionni, Nishant Agrawal, Rajani Ravi, Sian Jones, Mohammad O Hoque, William H Westra, David Sidransky, None, Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA Nature Communications. ,vol. 6, pp. 8258- 8258 ,(2015) , 10.1038/NCOMMS9258
Flore Kruiswijk, Christiaan F. Labuschagne, Karen H. Vousden, p53 in survival, death and metabolic health: a lifeguard with a licence to kill Nature Reviews Molecular Cell Biology. ,vol. 16, pp. 393- 405 ,(2015) , 10.1038/NRM4007
Shengliang Zhang, Lanlan Zhou, Bo Hong, A Pieter J van den Heuvel, Varun V Prabhu, Noel A Warfel, Christina Leah B Kline, David T Dicker, Levy Kopelovich, Wafik S El-Deiry, None, Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53. Cancer Research. ,vol. 75, pp. 3842- 3852 ,(2015) , 10.1158/0008-5472.CAN-13-1079